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Abstract
Background Bile duct injury (BDI) is the most common serious complication of laparoscopic cholecystectomy. To address 
this problem, a multi-society consensus conference was held to develop evidenced-based recommendations for safe chol-
ecystectomy and prevention of BDI.
Methods Literature reviews were conducted for 18 key questions across six broad topics around cholecystectomy directed 
by a steering group and subject experts from five surgical societies (SAGES, AHPBA IHPBA, SSAT, and EAES). Evidence-
based recommendations were formulated using the GRADE methodology. When evidence-based recommendations could 
not be made, expert opinion was documented. A number of recommendations for future research were also documented. 
Recommendations were presented at a consensus meeting in October 2018 and were voted on by an international panel of 
25 experts with greater than 80% agreement considered consensus.
Results Consensus was reached on 17 of 18 questions by the Guideline Development Group (GDG) and expert panel with 
high concordance from audience participation. Most recommendations were conditional due to low certainty of evidence. 
Strong recommendations were made for (1) use of intraoperative biliary imaging for uncertainty of anatomy or suspicion 
of biliary injury; and (2) referral of patients with confirmed or suspected BDI to an experienced surgeon/multispecialty 
hepatobiliary team.
Conclusion These consensus recommendations should provide guidance to surgeons, training programs, hospitals, and 
professional societies for strategies that have the potential to reduce BDIs and positively impact patient outcomes. Develop-
ment of clinical and educational research initiatives based on these recommendations may drive further improvement in the 
quality of surgical care for patients undergoing cholecystectomy.
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Background
Cholecystectomy is the most common operation performed 
worldwide by general surgeons with between 750,000 and 
1,000,000 performed in the U.S. annually. Laparoscopic 
cholecystectomy (LC) was introduced into clinical practice 
approximately 30 years ago, and it quickly became the gold 
standard operation for patients with symptomatic gallstones 
[1]. Because the benefits of laparoscopic compared to open 
cholecystectomy were so dramatic and readily apparent to 
both surgeons and patients, a “laparoscopic revolution” 
and Other Interventional Techniques 
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ensued that changed the face of surgery. However, there was 
a downside to the adoption of this procedure by an entire 
generation of surgeons who had no training in laparoscopic 
surgery, namely an increase in the number of bile duct inju-
ries (BDI) [2–4].
When one considers the high rate of wound, cardiac, 
pulmonary, and other complications, as well as pain and 
delayed return to work and activity that accompanied open 
cholecystectomy when it was the standard treatment for 
gallstone disease, laparoscopic cholecystectomy has been 
an incredible advance. Today, the vast majority of patients 
who undergo LC have an uneventful and rapid recovery and 
complete return to full activity within days of their proce-
dure. Although with advances in instrumentation, imaging, 
and surgical technique the incidence of BDI with LC has 
decreased somewhat in recent years, this complication still 
occurs at a frequency higher than the 0.1–0.2% rate reported 
in the open cholecystectomy era [5, 6].
Several recent large studies that have examined BDI and 
laparoscopic cholecystectomy have found major BDI rates 
of 0.15–0.36% and an overall biliary complication rate of 
1.5% if bile leaks are included [7–12]. In one study of the 
Gallriks database in Sweden, which captures > 90% of all 
cholecystectomies in that country, the rate of major BDI 
that required reconstruction was 0.36% and overall biliary 
complications were observed in 1.5% of patients [13]. In 
the U.S.A., administrative database studies have found an 
incidence of major BDI of 0.15–0.3% [7, 9, 10, 12], but 
Fig. 1  PRISMA search flow 
diagram demonstrating selec-
tion, screening, inclusion, and 
exclusion of articles for review. 
See Online Appendix 4 for 
studies not included in evidence 
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these may underestimate the actual incidence due to limita-
tions in using coding data to capture these injuries. Regard-
less, a 0.3% incidence of major BDI translates to between 
2300 and 3000 BDI’s annually in the USA alone. Biliary 
injury today is not just a phenomenon of LC but also can 
occur after open or laparoscopic converted to open chol-
ecystectomy [14, 15]. Bile duct injuries are also a source of 
increased morbidity and costs to the healthcare system. They 
can result in numerous re-interventions and hospitalizations, 
early and late complications, increased mortality, and poorer 
quality of life [8, 10, 16–18]. In one study, long-term mortal-
ity was > 8.8-fold above the expected and age adjusted rate 
of death [19]. BDIs also remain one of the most common 
causes for litigation against general surgeons [20–23].
In this context in 2014, the Society of Gastrointestinal 
and Endoscopic Surgeons (SAGES) formed the Safe Chol-
ecystectomy Task Force with the mission of creating a uni-
versal culture of safety around this operation and reducing 
Table 2  Guideline development group (leads and co-leads) and working group members
Group Guideline question # Lead Co-leads Working group members
1 1, 2, 3 Dan Deziel Marian McDonald Maria Altieri, Ben Veenstra, Justin Gerard, Ismael Domiguez-
Rosado, MacKenzie Landin
2 4, 5 Michael Brunt Adnan Alseidi Mike Ujiki Tim Schaffner, Eugene Ceppa, Sadiq Sikora, Sara Holden, Shanley 
Deal, Alessandro Paganini, Bailey Su
3 6, 7, 9 Dana Telem Taylor Riall Daniel Hashimoto, Chris Davis, Marie Crandall, Charles Lawrence, 
Chantal den Bakker, Leonie van Gastel
4 8, 11 Steven Strasberg Chet Hammill
Saxon Connor
Blaire Anderson, Chet Hammill, Megan Thomas, Scott Dojels, 
Waala Abdelmoaty
5 10, 12–17 Raj Aggarwal Carol Anne Moulton Phil Pucher, Fernando Santos, Nate Stoikes, Romeo Ignacio, Ryan 
Campagna, Sara Monafred, Domenech Asbun
6 18 Horacio Asbun Rowan Parks
Jaap Bonjer
Ewen Harrison, Luigi Boni, Oscar Imventarza, Rohan Jeyarajah, 
Marc Mesleh, Levan Tsalamaidze, Eline Zwart
Table 3  Guideline questions for prevention of bile duct injury during cholecystectomy (CCX)
1. Should the critical view of safety (CVS) vs. another (infundibular, top down, IOC) be used to mitigate the risk of BDI during laparoscopic 
cholecystectomy (LC)?
2. Should the “fundus-first” (top down) technique of total cholecystectomy vs. subtotal cholecystectomy be used when the CVS cannot be 
achieved?
3. Should the CVS be documented during laparoscopic cholecystectomy with still doublet photos vs. operative notes vs. video?
4. Should intraoperative biliary imaging (intraoperative cholangiography, US) vs. no intraoperative biliary imaging be used to mitigate the risk 
or severity of bile duct injury during laparoscopic cholecystectomy?
5. Should intraoperative near-infrared biliary imaging vs. IOC or white light be used in limiting the risk of BDI?
6. Should surgical risk stratification vs alternative or no risk stratification be used for mitigating the risk of BDI?
7. Should risk stratification that accounts for cholecystolithiasis vs. no/alternate risk stratification be used for mitigating the risk of BDI?
8. Should immediate cholecystectomy (within 72 h from symptom onset) vs. CCX delayed beyond 72 h (72 h to 10 days vs. 6–12 weeks 
vs. > 12 weeks) be used for acute cholecystitis?
9. Should subtotal CCX vs. total laparoscopic or open CCX be used for mitigating the risk of BDI in marked acute inflammation or chronic 
biliary inflammatory fusion (BIF)?
10. Should 4-port lap cholecystectomy vs. reduced port/single incision LC vs robotic LC be used for limiting the risk or severity of BDI?
11. Should interval/delayed LC vs. no additional treatment be used for patients previously treated by percutaneous cholecystostomy?
12. Should conversion of laparoscopic to open cholecystectomy vs. no conversion be used for limiting the risk or severity of BDI in the dif-
ficult laparoscopic cholecystectomy?
13. Should a time out to verify the CVS vs. no time out be used for limiting the risk or severity of BDI?
14. Should two vs. one surgeon(s) be used for limiting the risk or severity of BDI?
15. Should CVS coaching of surgeon vs. no coaching be used for limiting the risk or severity of BDI?
16. Should training by simulation or video-based education vs alternative surgeon training be used for limiting the risk or severity of BDI?
17. Should more vs less surgeon experience be used for mitigating the risk of BDI?
18. Should immediate reconstruction by the operating surgeon vs referral to a specialty center be used for patients with BDI during cholecys-
tectomy?
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biliary injuries. As an initial step, this group undertook a 
Delphi consensus process on strategies to reduce biliary 
injuries [24] and held subsequent collaborative meeting 
programming with other surgical societies. In 2016, plan-
ning began for a multi-society consensus conference on 
prevention of bile duct injury during cholecystectomy, 
that included SAGES, the Americas Hepato-Pancreato-
Biliary Association (AHPBA), the International Hepato-
Pancreato-Biliary Association (IHPBA), the Society for 
Surgery of the Alimentary Tract (SSAT), and the European 
Association for Endoscopic Surgery (EAES). The process 
led to the development of a series of key questions to be 
addressed by comprehensive literature review, formulation 
of recommendations based on the evidence, and conven-
ing of a consensus meeting in Boston in October 2018 
with expert and audience voting panels. The results of this 
process and recommendations from the consensus meeting 
form the basis of this guideline document.
Guideline scope, purpose, and methods
The aims of the consensus meeting were to identify opti-
mal strategies for the prevention of bile duct injury during 
cholecystectomy and to develop and disseminate evidence-
based practice recommendations for safe cholecystectomy. 
The guideline takes the surgeon–patient perspective. Top-
ics covered include anatomic identification techniques, 
disease factors, surgical techniques, surgeon education, 
and intraoperative management of injury. Intended users of 
the guideline are general surgeons, hepatobiliary surgeons, 
and surgical trainees. It is anticipated that use of the guide-
line will help minimize the variability in surgical care for 
patients undergoing cholecystectomy, reduce the risk of 
BDI, and improve associated morbidity, cost, and quality 
of life. This guideline should also directly inform efforts 
by surgical training programs, hospitals, and professional 
associations to create and disseminate interventions to 
enhance patient safety in cholecystectomy and improve 
patient outcomes.
Detailed in Online Appendix 1 (http://links .lww.com/
SLA/B986) and summarized in Table 1 [25–34], the over-
all guideline development process was guided by SAGES 
policies and procedures for guideline development to meet 
recommendations for trustworthy guidelines by the Institute 
of Medicine (now the National Academy of Medicine) and 
the Guidelines International Network [35–38].
Results of literature screening
A total of 2798 records were identified (Fig. 1). Follow-
ing screening for eligibility, 451 records (representing 
unique studies) were included for potential data extraction 
and assessment of risk of bias. However, 297 studies either 
incompletely reported outcome data or had poor face valid-
ity, obviating detailed data extraction (see Online Appen-
dix 5, http://links .lww.com/SLA/B990). Finally, 154 studies 
informed this guideline.
Guideline recommendations
Question 1 Should the critical view of safety (CVS) versus 
other techniques (e.g., infundibular, top down, or intraop-
erative cholangiography) be used to mitigate the risk of bile 
duct injury during laparoscopic cholecystectomy?
Recommendation In patients undergoing laparoscopic chol-
ecystectomy, we suggest that surgeons use the critical view 
of safety (CVS) for anatomic identification of the cystic duct 
and artery (expert opinion).
Summary of evidence No direct comparative evidence was 
identified to support the critical view of safety (CVS) over 
other methods for anatomic identification. The evidence for 
intraoperative cholangiogram (IOC) vs. no IOC is addressed 
under guideline question 4. Restricting the meta-analysis to 
single arm cohort studies of sample size ≥ 400 cases, the 
pooled incidence of BDI was 2 in one million cases when 
CVS was used (n = 4 studies with n = 5446 cases) [39–42] 
versus a pooled BDI incidence of 1.5 in 1000 cases when the 
infundibular technique was used (n = 3 studies with 10,060 
cases). [43–45] This comparison, however, was deemed 
high risk of bias by the GDG because of concerns regarding 
exchangeability of populations between the two interven-
tion groups.
Narrative synthesis Forty-five full-text articles identified 
by the search methodology were reviewed that included 
three systematic reviews.
Use of critical view of safety The use of the critical view 
of safety (CVS) is based on two lines of indirect evidence. 
First, several large single institutional studies with a suf-
ficient number of cases to potentially encounter BDI report 
lower than expected rates of BDI with routine use of the 
CVS [39, 41, 42, 46]. In addition, as noted above in the sum-
mary of evidence, the pooled BDI incidence from studies 
reporting use of the CVS is lower than that from studies that 
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describe identification primarily by what would be consid-
ered an infundibular approach [39–45, 47–49].
A second line of indirect evidence for use of the CVS 
comes from case series of BDIs that have analyzed the cir-
cumstances of the injury which have demonstrated that BDIs 
usually occurred in cases when the CVS was not attained. 
An analysis of the operative reports from 528 BDI cases 
(396 excluding cystic duct leaks, 479 laparoscopic cases) 
treated at a single institution in Amsterdam found documen-
tation of the CVS in only 33 cases (6.3%) [50]. Similarly, 
an examination of operative reports from 21 patients with 
BDI identified the infundibular method in all cases [51]. One 
study that reviewed 65 videos of laparoscopic cholecystec-
tomy with complications found that videos from 11 BDI 
cases had not achieved the CVS while a control group with-
out complications after LC 72% had achieved the CVS [52].
The ability to achieve the CVS in 85–95% of attempted 
cases indicates that it is implementable [39–41]. Moreover, 
there is no substantial evidence that reasonable efforts to 
achieve the CVS have been associated with undesirable 
effects. The literature search identified only one report of 
BDI occurring during an attempt to achieve the CVS [53].
A systematic review (R-AMSTAR score [25] 23/44) of 
methods for intraoperative assessment of biliary anatomy 
for prevention of BDI included four studies on the CVS 
with 4593 patients [54]. One retrospective study compared 
patients undergoing laparoscopic cholecystectomy by the 
infundibular approach to those using the CVS [55]. While 
no BDIs occurred, the study was seriously underpowered 
to assess BDI as an outcome metric. It was also critically 
flawed in that it assumed a particular method was used for 
identification based on the experience of the surgeon without 
objective documentation of the actual method used.
Use of fundus-first dissection Use of the “fundus-first” or 
“top-down” method for intraoperative anatomic identifica-
tion during laparoscopic cholecystectomy was examined in 
a review (R-AMSTAR score 18/44) of operative techniques 
during operations that were considered difficult based on 
conversion rate or iatrogenic complications (without specifi-
cation of BDI occurrence) [56]. Eleven studies with a total of 
1100 patients from 1995 to 2009 were reported. The authors 
did not detail the studies reviewed, but concluded that there 
was evidence for the safety and efficacy of this technique. 
The 11 studies referenced in this review were individually 
re-examined in full-text format [46, 57–66].
The selection criteria for patients undergoing laparo-
scopic fundus-first cholecystectomy were heterogeneous. 
Nine studies with a total of 934 patients reported no bile 
duct injury [57–62, 64–66]. However, in the largest series of 
500 patients, the operative technique involved identification 
and tape ligation of the cystic duct prior to fundus-first dis-
section of the gallbladder [58]. When reported, conversion 
to open cholecystectomy occurred in 16 of 312 (5.1%) cases 
and complications in 10 of 285 (3.5%) cases. One additional 
single-center study, not included in the review described, 
reported no complications among 81 patients undergoing 
laparoscopic fundus-first dissection performed after the 
cystic duct was clipped and the cystic artery divided [67].
A prospective trial evaluated patients with contracted 
gallbladders as determined by preoperative sonographic 
criteria [68]. Patients were randomized by alternate num-
bers to either conventional laparoscopic cholecystectomy or 
to laparoscopic fundus-first dissection. Ten patients were 
excluded and two additional patients were added based on 
intraoperative finding of a contracted gallbladder. Among 
the 31 patients undergoing standard laparoscopic cholecys-
tectomy, there were 10 conversions, 7 with complications, 
and 2 with BDI. There were no conversions or BDIs among 
the 33 patients undergoing fundus-first operations and one 
patient had a complication.
Two case series of BDIs discuss potential implications of 
a fundus-first gallbladder dissection. A series of 182 BDIs 
(30 during laparoscopic cholecystectomy) from four univer-
sity hospitals in China noted that all BDIs occurred when 
dissection commenced in the region of the hepatocystic 
triangle [69]. Thus, dissection from the fundus was con-
sidered the optimal choice during cholecystectomy. On the 
other hand, a series of 8 devastating vasculo-biliary injuries 
found that all occurred with a fundus-first dissection after 
conversion of laparoscopic operation for severely inflamed 
gallbladders [70].
Justification Given the available evidence, the GDG relied 
on expert opinion to make this recommendation. Although 
studies were not designed to directly answer the effective-
ness of the CVS, the anticipated effect would have been 
large. Event analysis of BDIs implicates methods of ana-
tomic identification other than the CVS as potential causes of 
injury in essentially all cases evaluated. CVS is attainable in 
a majority of cases when attempted routinely. The safe extent 
of dissection in any case must always be tempered by surgi-
cal judgment, but there is no evidence that reasonable efforts 
to achieve the CVS have been harmful, and, therefore, use of 
CVS is logical. When operative conditions are difficult, and 
the CVS cannot be reasonably achieved, alternative methods 
for either anatomic definition or conclusion of the operation 
are critical to prevention of BDI or other injury.
Question 2 Should the fundus-first (top down) technique 
versus subtotal cholecystectomy be used to mitigate the risk 
of bile duct injury when the CVS cannot be achieved during 
laparoscopic cholecystectomy?
Recommendation When the critical view of safety can-
not be achieved and the biliary anatomy cannot be clearly 
defined by other methods (e.g., imaging) during laparoscopic 
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cholecystectomy, we suggest that surgeons consider subtotal 
cholecystectomy over total cholecystectomy by the fundus-
first (top down) approach (expert opinion).
Summary of evidence No direct comparative evidence 
addressed this key question. A number of non-comparative 
case series report low BDI risk with the application of both 
these techniques. An indirect comparison of this evidence 
was not considered appropriate by the GDG because the 
majority of non-comparative studies were underpowered, 
and the comparison was flawed due to confounding by sur-
gical expertise, patient population selection, and subjectiv-
ity in the judgment of severity of inflammation. One study 
implicated the top-down approach under difficult conditions 
as a risk factor for BDI and vascular injury [70].
Narrative synthesis Thirty-five full-text articles identi-
fied by the search methodology are summarized below. Data 
regarding use of laparoscopic fundus-first dissection has 
been summarized in the section on Question #1.
Laparoscopic subtotal cholecystectomy
Reviews and observational cohort studies Three reviews 
provide generalized information about the outcomes of lapa-
roscopic subtotal cholecystectomy. A systematic review and 
meta-analysis of 30 studies of subtotal cholecystectomy for 
difficult gallbladders included 898 laparoscopic operations, 
99 laparoscopic operations converted to open, and 234 pri-
mary open operations [71]. One BDI was reported (0.08%). 
Subgroup analysis of 471 completed laparoscopic cases 
found bile leaks in 149, retained stones in 8, morbidity in 9, 
and one mortality. A review of 28 studies of 1280 patients 
undergoing subtotal cholecystectomy included 154 laparo-
scopic subtotal cholecystectomies [72]. Conversion occurred 
in 13 of 95 reported cases; there was no detailed informa-
tion on BDI or other complications. A review of operative 
techniques in difficult cholecystectomy included 12 studies 
with 822 patients having laparoscopic subtotal cholecystec-
tomy [56]. The authors stated that there was evidence for the 
safety and efficacy of this technique.
Full-text review of articles cited in the above reviews was 
performed and the following outcomes for laparoscopic sub-
total cholecystectomy were tabulated: BDI, 1/657 (0.15%); 
conversion 22/637 (3.5%); morbidity 164/637 (25.7%); 
mortality 2/637 (0.3%); bile leak 161/580 (27.8%); retained 
stones 14/458 (3.1%) [44, 45, 63, 73–80]. Six additional 
cohort studies of laparoscopic subtotal cholecystectomy that 
were unique to those cited in the reviews were identified and 
included 796 patients with the following outcomes reported: 
BDI 1/370 (0.2%); conversion 96/778 (12.3%); morbidity 
45/340 (13.2%); mortality 0/575; bile leak 26/301 (8.6%). 
[46, 81–85].
Comparative studies No studies directly compared laparo-
scopic subtotal cholecystectomy and fundus-first dissection 
as separate and distinct operations. However, laparoscopic 
subtotal cholecystectomy has been compared to operative 
alternatives in several formats.
Laparoscopic subtotal cholecystectomy vs. laparoscopic 
total cholecystectomy An analysis from the University Health 
System Consortium database compared outcomes of 487 
patients undergoing laparoscopic subtotal cholecystectomy 
to laparoscopic total cholecystectomy [86]. A 1:1 propensity 
score match was used to account for differences in clinical 
and demographic factors. After matching, there were no dif-
ferences in hospital length of stay (LOS), readmission rates, 
or mortality, but subtotal operations had higher total direct 
costs. BDI was not specified. A prospective, non-randomized 
trial compared results between patients with preoperative 
predictors for difficult cholecystectomy based on an objec-
tive scoring system [87]. Sixty-five patients who underwent 
a version of subtotal laparoscopic cholecystectomy had no 
BDI and one conversion. Sixty patients with standard total 
laparoscopic cholecystectomy incurred 2 BDIs (p = 0.134) 
and 6 conversions (p = 0.04).
Laparoscopic subtotal cholecystectomy vs. converted or 
primary open subtotal cholecystectomy In a meta-analysis 
of operations for difficult gallbladders, laparoscopic subto-
tal cholecystectomy compared favorably to open subtotal 
cholecystectomy with less risk of sub-hepatic collection 
(OR 0.4, 95% CI 0.2–0.9), retained stones (OR 0.5, 95% CI 
0.3–0.9), wound infection (OR 0.07, CI 0.04–0.2), reopera-
tion (OR 0.5, 95% CI 0.3–0.9), and mortality (OR 0.2, 95% 
CI 0.05–0.9), but was associated with more bile leaks (OR 
5.3, 95% CI 3.9–7.2) [71].
A retrospective cohort analysis of the Nationwide Inpa-
tient Sample database of 10,872 “damage control” gallblad-
der operations that included laparoscopic and open subtotal 
cholecystectomy and “trocar cholecystostomy” [88]. There 
were 360 BDIs reported with a 13.6% morbidity rate and 
7.4% in-hospital mortality rate. Laparoscopic subtotal 
cholecystectomy was attempted in 5164 cases with 2204 
cases converted (42.7%). The specific number of BDIs in 
each cohort was not reported, but no statistical difference 
between converted and non-converted cases was observed 
(p = 0.159). A single health system comparison of laparo-
scopic subtotal cholecystectomy (n = 24) and primary open 
subtotal cholecystectomy (n = 41) found similar postopera-
tive complications with no BDIs, but longer postoperative 
LOS for open procedures [82].
Laparoscopic and open subtotal cholecystectomy vs. total 
cholecystectomy A retrospective multi-center study from The 
Netherlands of 191 subtotal cholecystectomies reported 175 
laparoscopic subtotals with 45 conversions (25.7%) [85]. A 
subgroup of subtotal cholecystectomy patients (laparoscopic 
and converted) was compared to a contemporaneous group 
of 152 patients with converted total cholecystectomy. There 
was one BDI in each group. The subtotal cholecystectomy 
group had significantly higher rates for cystic duct leak (13% 
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vs. 2%), biliary event recurrence (15% vs. 3%), readmissions 
(18% vs. 8%), and re-interventions (34% vs. 18%). The con-
verted total cholecystectomy group had significantly more 
frequent wound infections (17% vs. 6%) and increased LOS 
(median 5 vs. 4 days).
A single health system study reported a 2:1 propensity 
matched comparison of 130 patients with standard chol-
ecystectomy to 65 patients with subtotal cholecystectomy 
(laparoscopic, converted and primary open) [82]. Subtotal 
operations were associated with significantly more surgical 
site infections, re-interventions, and longer LOS.
Justification The GDG reasoned that when inflammation 
prevents anatomic identification by the CVS or by imag-
ing, avoiding dissection of ductal structures would have an 
anticipated large effect in reducing BDI. A subtotal chol-
ecystectomy approach that does not enter the hepatocystic 
triangle was considered preferable to pursuit of total chol-
ecystectomy under these circumstances. The GDG unani-
mously agreed that the terms “subtotal cholecystectomy” 
and “top down” are not mutually exclusive and, in fact, 
forms of subtotal cholecystectomy can be performed with a 
dissection that proceeds from the region of the fundus [82, 
86]. Therefore, under challenging conditions, BDI risk can 
be minimized via either subtotal or top down cholecystec-
tomy if dissection in the hepatocystic triangle is avoided.
Question 3 Should video documentation of the CVS (alone 
or in addition to operative notes) versus photo documenta-
tion (alone or in addition to operative notes) be used for 
limiting the risk or severity of BDI during laparoscopic 
cholecystectomy?
Recommendation No recommendation could be provided 
for this question due to a lack of agreement of the expert 
panel and concerns regarding feasibility, acceptability, and 
medico-legal considerations.
Summary of evidence No evidence was found that directly 
compared the impact of the various alternatives for CVS 
documentation requirements on outcomes of bile duct injury 
and other complications of surgery. Indirect evidence on 
the proxy outcome of the quality of documentation of CVS 
consisted of five observational studies with 368 patients 
[89–93]. Accurate documentation of the CVS by descrip-
tion in operative notes is poor [90–92]. Photographs of the 
CVS from two views have been superior to photographs with 
one view [93]. Intraoperative cholangiography was judged 
superior to single view photographs of the CVS for docu-
mentation of biliary anatomy [89]. Video documentation has 
been reported to be superior to operative notes [92, 93] and 
to CVS photographs with 2 views [90]. No correlation has 
been established with any clinical outcomes.
Justification Because direct evidence for BDI was not 
found, the GDG considered indirect linked evidence.
The GDG opined that surgeons should strive to obtain the 
CVS during laparoscopic cholecystectomy to minimize BDI 
risk (see recommendation to Question 1). The GDG felt that 
encouraging a more accurate method for documentation of 
the CVS might promote its wider use and enhance patient 
safety. The GDG agreed that the quality of CVS documenta-
tion, as judged by external independent assessors, is a rel-
evant although uncertain proxy for BDI risk.
There was no consensus on this recommendation at the 
consensus conference. There was considerable discussion 
about medico-legal implications and push back from sur-
geons. Alternate wording that was considered included sur-
geons "be encouraged to document CVS by doublet pho-
tography or video." Another suggestion was that surgeons 
document in written reports how the anatomy was identified 
(since this is often omitted or unclear). The concept would 
not be to establish a mandate, but rather to increase over 
time use of doublet photography (or video documentation) 
in surgical practice. It was noted that the value of documen-
tation as a teaching or quality assurance tool is evident and 
has previously been shown to improve the quality of health-
care delivered [94]. Ultimately, due to stakeholder concerns 
regarding acceptability, a recommendation was not made.
Question 4 Should intraoperative biliary imaging (e.g., 
intraoperative cholangiography, ultrasound) versus no intra-
operative biliary imaging be used for mitigating the risk of 
bile duct injury during laparoscopic cholecystectomy?
Recommendation In patients with acute cholecystitis or a 
history of acute cholecystitis, we suggest the liberal use of 
intraoperative cholangiography during laparoscopic chol-
ecystectomy to mitigate the risk of bile duct injury (con-
ditional recommendation, very low certainty of evidence). 
Surgeons with appropriate experience and training may use 
laparoscopic ultrasound imaging as an alternative to IOC 
during laparoscopic cholecystectomy.
In patients with uncertainty of biliary anatomy or sus-
picion of bile duct injury during laparoscopic cholecystec-
tomy, we recommend that surgeons use intraoperative biliary 
imaging (in particular intraoperative cholangiography) to 
mitigate the risk of bile duct injury (strong recommenda-
tion, very low certainty of evidence).
Given that the evidence for the benefit of IOC in elective 
non-acute cholecystectomy is inconclusive, no recommenda-
tion addressing this scenario could be made.
Summary of evidence Evidence comparing intraopera-
tive cholangiography (IOC) versus no intraoperative biliary 
imaging was considered in panel deliberations. No conclu-
sive evidence was found for other types of biliary imaging. 
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Randomized controlled trial (RCT) evidence (n = 9) for IOC 
was too underpowered for meaningful synthesis. Pooled evi-
dence from 14 studies [8, 9, 95–106] that included 2.5 mil-
lion patients demonstrated findings favoring IOC over no 
IOC in most of the studies providing adjusted estimates of 
effect, but the benefit was greatest in the subgroup analysis 
for patients with acute cholecystitis. For the subgroup of 
patients with intraoperatively suspected BDI, the use of IOC 
led to an almost threefold increase in the odds of recognition 
of BDI compared with non-use of IOC.
Narrative synthesis A systematic review of randomized 
trials that compared IOC to no IOC in patients undergoing 
cholecystectomy identified 8 studies (including one of open 
cholecystectomy) that met inclusion criteria (R-AMSTAR 
score 31.5) [107]. Only two major BDIs were identified in 
1715 patients and there were two avulsion injuries of the 
cystic duct after IOC. Overall, the BDI rate was 0.2% and 
major BDI rate 0.1%. One additional randomized trial of 
371 patients had one BDI in each group and was similarly 
inconclusive [108]. Because BDI is an uncommon event, 
further randomized trials would need an estimated minimum 
of 4500 patients per arm to show a difference in outcomes 
regarding use of IOC or other interventions and would not 
be practical to perform [109].
The incidence of BDI during cholecystectomy with and 
without IOC was pooled from 14 large studies of mostly 
administrative data of 2,540,700 cholecystectomies [8, 9, 
95–106]. The studies were at moderate to high risk of bias 
due to the nature of administrative coding data. Overall, 
the analysis showed a reduced incidence of BDI with the 
use of IOC (OR 0.78 [0.63–0.96], p < 0.0001). When risk 
adjusted, a similar though slightly lesser effect was observed 
(OR 0.81, 0.62–1.07). A 1987–2001 study from the Swed-
ish inpatient registry reported 613 BDIs in 152,776 chol-
ecystectomies and showed a 34% risk reduction in 94,569 
patients in whom IOC was performed (multivariate analysis 
OR 0.66, 95% CI 0.54–0.79) [105]. The GallRiks National 
Swedish registry for gallstones surgery analyzed outcomes 
in 51,041 cholecystectomies from 2005 to 2010 [8]. A total 
of 74 BDIs, defined as any damage to the bile duct or biliary 
tree including bile leaks, were identified (1.5%). The use of 
IOC or intent to use IOC was associated with a reduced risk 
of bile duct injury only in patients with acute cholecystitis 
(OR 0.44, 95% CI 0.30–0.63) or a history of acute cholecys-
titis (OR 0.59, 95% CI 0.35–1.00). No association between 
cholangiogram use and rate of BDI was found in patients 
who did not have acute cholecystitis or a history of acute 
cholecystitis (OR 1.06, 95% CI 0.75–1.49).
The rate of intraoperative recognition of injury was 
assessed by meta-analysis of 8 studies that included 1256 
BDI’s and compared IOC vs no IOC [13, 96, 98, 100, 102, 
110–112]. The use of IOC was associated with increased 
intraoperative recognition of BDI compared to no IOC (OR 
2.92, 95% CI 1.55–5.68, p = 0.014).
Ultrasound has not been evaluated as extensively as IOC. 
Two systematic reviews found that laparoscopic ultrasound 
(LUS) and IOC have similar success rates for visualization 
of the biliary anatomy [54, 113]. One retrospective cohort 
study found 11 BDIs in 594 cases without LUS vs 0 in 248 
cases with LUS (p = 0.04) [114]. A prospective multi-center 
cohort study reported no BDI and only three bile leaks in 
1381 patients [115]. These studies do not directly address 
LUS vs IOC and the incidence of BDI but do suggest that 
ultrasound in experienced hands has excellent results in 
delineating biliary anatomy.
Justification Pooled evidence from 14 studies of > 2.5 
million patients demonstrated findings favoring IOC over 
no IOC in most studies reporting adjusted risk estimates, but 
the benefit was greatest in patients with acute cholecystitis. 
The GDG also deliberated on the alternative approach of 
using laparoscopic ultrasound imaging. No evidence was 
found to support or refute its use. In trained hands, ultra-
sound may be an appropriate alternative to IOC.
Multiple studies have shown that IOC is associated with 
a higher rate of intraoperative recognition of BDI. Although 
the certainty of evidence is very low, this is a consistent find-
ing across studies. The GDG concluded that the subgroup 
of patients with uncertain anatomy or strong intraoperative 
suspicion of BDI will have a significantly higher baseline 
risk of BDI as well as at a higher risk for life-threatening 
complications of undetected/unrepaired BDI. For this sub-
group of patients, the GDG invoked one the five paradig-
matic GRADE scenarios Life-threatening Situation for 
strong recommendations based on "low or very low certainty 
evidence" [34]. The potential benefit of IOC is early recogni-
tion and avoidance of potentially increasing the severity of 
BDI. This benefit includes avoidance of excision of a portion 
of the bile duct and a higher level of injury which is often 
more difficult to repair and reconstruct.
Question 5A Should intraoperative near-infrared (NIR) bil-
iary imaging versus intraoperative cholangiogram (IOC) be 
used for limiting the risk or severity of bile duct injury dur-
ing laparoscopic cholecystectomy?
Recommendation No recommendation was made as cur-
rent evidence comparing near-infrared cholangiography for 
identification of biliary anatomy during cholecystectomy to 
intraoperative cholangiography is insufficient.
Summary of evidence There was no direct evidence 
available for BDI or other outcomes for NIR vs IOC. The 
outcomes for ductal visualization were considered indirect 
evidence for BDI. Four observational studies provided data 
for the surrogate outcomes of visualization of cystic duct, 
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common bile duct, and hepatic duct [116–119]. Pooling of 
the data for visualization of each structure yielded incon-
sistent findings: RR for cystic duct (CD) visualization was 
1.1 (95% CI 1.00–1.35; 4 studies; total patients = 430). RR 
for common bile duct (CBD) was 1.0 (95% CI 0.97–1.03; 4 
studies; total patients = 430). RR for common hepatic duct 
was 0.76 (95% CI 0.58–1.01, 4 studies; total patients = 300), 
p = NS [120].
Narrative synthesis In the systematic review of 
mostly prospective cohort studies by Vlek et  al. [120] 
(R-AMSTAR-29), 19 studies were reviewed and data pooled 
from four observational studies for surrogate identification 
of the cystic duct, common bile duct and common hepatic 
duct as shown above. Most of the studies reviewed were 
highly subject to bias and did not compare ICG visualiza-
tion to white light. There was considerable heterogeneity 
in the populations studied. For example, both complicated 
and uncomplicated gallstone diseases were pooled and there 
were different definitions of complicated disease within the 
studies.
A review by Pesce et al. (R-AMSTAR-27) [121] analyzed 
16 studies involving ICG in both laparoscopic and robotic 
cholecystectomies. Detection rates of the biliary anatomy 
in 590 pooled patients were as follows: cystic duct-96.2% 
(94.7–97.7%); common hepatic duct-78.1% (74.8–81.4%); 
cystic duct-common hepatic duct junction-72.0% 
(69.0–75.0%); and common bile duct-86.0% (83.3–88.8%). 
No comparison was done with IOC or white light.
Question 5B Should intraoperative near-infrared biliary 
imaging with white light versus white light biliary imaging 
alone be used for limiting the risk or severity of bile duct 
injury during laparoscopic cholecystectomy?
Recommendation We suggest that the use of near-infrared 
imaging may be considered as an adjunct to white light 
alone for identification of biliary anatomy during cholecys-
tectomy (conditional recommendation, very low certainty 
of evidence). The GDG noted that relying on near-infrared 
imaging must not be a substitute for good dissection and 
identification technique (expert opinion).
Summary of evidence There was no direct evidence for 
BDI or other decision-making outcomes. One RCT (N = 640) 
demonstrated findings favoring NIR for the visualization of 
various ductal structures (cystic duct, common hepatic duct 
and the CBD) pre and post-dissection. These were consid-
ered proxy evidence for BDI.
Narrative synthesis: The results of a single-blind multi-
center, randomized controlled trial of NIR and white light 
(N = 321) to white light alone (N = 318) were not available 
prior to the consensus conference but has recently been 
published [122]. The trial compared detection rates of 
seven biliary structures: cystic duct (CD), right hepatic duct 
(RHD), common hepatic duct (CHD), and common bile duct 
(CBD), cystic-common bile duct junction (CCBDJ), cystic-
gallbladder junction (CGJ), and accessory ducts (AD). 
Detection rates were statistically and significantly higher 
for the NIR group for each structure before dissection: OR 
ranges from 2.3 (95% CI 1.6–3.2) for the CGJ to 3.6 (95% CI 
1.6–9.3) for the RHD. After dissection, similar differences 
were observed for all structures except the CD and CGJ, 
which were not significantly different.
Factors that affected detection rates were also assessed 
and body mass index (BMI), level of inflammation, patient 
age, and surgeon experience were found to be significant. 
Overall, BMI reduced visualization by 6% per BMI unit 
increase; however, visualization remained better with NIR 
compared to white light. The detection rate was approxi-
mately 40–70% less among patients with moderate-to-
severe versus minimal inflammation. Every increased year 
of patient age reduced detection of the RHD and CHD by 4% 
and 2% after dissection, and the CGJ by 1% both before and 
after dissection. Surgeon experience in years was directly 
proportional to detection rates as well. There were two 
“mild” BDIs out of 639 patients, both in the white light 
only group and resulted in conversion to open operation 
(p = 0.25). A limitation of the study is that surgeons were 
not blinded to the method of imaging and anatomic structure 
detection. Of note, a 2nd randomized trial comparing NIR 
to white light is currently underway (FALCON trial, NCT 
02558556).
Justification The one RCT (N = 640 patients) demon-
strated findings favoring NIR for the visualization of various 
ductal structures (cystic duct, common hepatic duct and the 
CBD) pre- and post-dissection. The risk of bias was rated as 
serious due to outcome ascertainment bias as the surgeons 
were non-blinded. The indirectness of the findings was rated 
very serious because of concerns about generalizability of 
the findings to general surgical practice as well as concerns 
about the surrogacy of ductal visualization for BDI. Impor-
tantly, the GDG noted that relying on NIR must not be a 
substitute for good dissection and identification technique.
Recommendations for future studies Near-infrared chol-
angiography should be assessed in large trials compared to 
white light alone and to IOC with risk stratification and risk 
adjustment. Because BDI is unlikely to be captured in such 
trials, we additionally suggest these trials focus on proxy 
outcomes such as visualization of ductal structures, abil-
ity to obtain the critical view of safety, and complications 
including conversion to open cholecystectomy. In particu-
lar, this technology should be studied in difficult cholecys-
tectomy patient populations that include those with acute 
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cholecystitis or a history of acute cholecystitis, severe 
chronic cholecystitis, and obese patients.
Question 6 Should surgical (complexity) risk stratifica-
tion versus alternative or no risk stratification be used for 
mitigating the risk of BDI associated with laparoscopic 
cholecystectomy?
Recommendations 
A1 For patients with acute cholecystitis, we suggest that 
surgeons may use the Tokyo Guidelines 18 (TG18), 
AAST classification, or another effective risk stratifica-
tion model for grading for severity of cholecystitis and 
for patient management (expert opinion).
A2 During operative planning of laparoscopic cholecystec-
tomy and intraoperative decision-making, we suggest 
that surgeons consider factors that potentially increase 
the difficulty of laparoscopic cholecystectomy such as 
male gender, increased age, chronic cholecystitis, obe-
sity, liver cirrhosis, adhesions from previous abdominal 
surgery, emergency cholecystectomy, cystic duct stones, 
enlarged liver, cancer of gallbladder and/or biliary tract, 
anatomic variation, bilio-digestive fistula, and limited 
surgical experience (expert opinion).
Summary of evidence No articles directly compared the 
incidence of BDI when a risk stratification system was used 
vs. when a risk stratification system was not used. There are 
many prognostic risk association studies, but these do not 
evaluate the effectiveness of using this prognostic informa-
tion to alter management and mitigate the risk of BDI. There 
is, however, evidence to indicate that the presence of acute 
cholecystitis increases the risk of mortality as well as BDI. 
In addition, grading/risk stratification systems for the sever-
ity of acute cholecystitis exist, including the Tokyo Guide-
lines (TG) 2013 and 2018 [94, 123, 124] and the American 
Association of Surgery for Trauma (AAST) severity grading 
[125]. Furthermore, there is evidence that the risk of BDI 
increases with the severity of inflammation as proposed by 
the TG 13/18.
Narrative synthesis The association between TG13 sever-
ity of cholecystitis and BDI was best demonstrated in a 2016 
a case–control study by Tornqvist et al. [126]. In this study, 
the TG13 risk stratification model was applied retrospec-
tively to 158 patients who suffered a BDI during laparo-
scopic cholecystectomy and 623 matched controls who 
underwent laparoscopic cholecystectomy without BDI. The 
odds of BDI doubled among patients with acute cholecys-
titis (OR 1.97 95% CI 1.05–3.72) and the risk increased as 
the grade of inflammation increased. When compared to no 
cholecystitis, the odds of BDI increased from 0.96 (95% CI 
0.41–2.25) in Tokyo grade I cholecystitis, to 2.41 (95% CI 
1.21–4.80) in grade II, and 8.43 (95% CI 0.97–72.9) in grade 
III compared to no cholecystitis. The mortality was also 
increased with grade from 5.4% for grade III, 0.8% for grade 
II, and 1.2% for grade I cholecystitis (not risk adjusted).
The TG are currently the only risk stratification model 
that risk stratifies and guides management of patients with 
acute cholecystitis based on the severity grade. Controversy 
does exist regarding the validity of the Tokyo guidelines. 
A study by Hernandez et al. compared the AAST vs. TG13 
severity grading systems for predicting postoperative out-
comes in patients with acute cholecystitis and showed that 
the AAST criteria had better area under the curve (AUC) 
for predicting mortality (AUC 0.86 vs. 0.73), complications 
(AUC 0.76 vs. 0.63), and need for cholecystostomy tubes 
(AUC 0.80 vs. 0.68), all p < 0.05 [125]. Another study dem-
onstrated that TG13 missed 35% of patients with gangre-
nous/acute cholecystitis on final pathology [127].
A systematic review of factors that make laparoscopic 
cholecystectomy difficult [56] included 91 articles with 3 
meta-analyses of randomized trials, 5 controlled randomized 
trials, 8 well-designed controlled studies, 13 well-designed 
experimental studies, and 63 descriptive retrospective stud-
ies. There was a total of 324,553 patients. Factors associated 
with difficult laparoscopic cholecystectomy included male 
gender, increased age, acute cholecystitis, chronic chol-
ecystitis, obesity, liver cirrhosis, adhesions from previous 
abdominal surgery, emergency cholecystectomy, cystic duct 
stone, large liver, big gallbladder, cancer of the gallbladder 
and/or biliary tract, anatomic variation, bilio-digestive fis-
tula, and surgeon experience. The association of these risk 
factors with BDI was not specifically examined.
Justification No evidence was found to support evidence-
based recommendations. The GDG suggestions were, there-
fore, based on existing evidence of association. Given that 
risk stratification models demonstrate an association of more 
severe acute cholecystitis with higher rates of BDI, and com-
plications and given the minimal risk of using these models, 
the GDG felt that guiding surgical intervention based on risk 
assessment could potentially mitigate the risk and severity 
of BDI.
Question 7 Should risk stratification that accounts for chol-
ecystolithiasis versus no/alternate risk stratification be used 
for mitigating the risk of BDI associated with laparoscopic 
cholecystectomy?
Recommendation No recommendation was made as no 
risk prediction models exist that incorporate the presence 
or absence of gallstones as a factor that increases bile duct 
injury or difficulty of laparoscopic cholecystectomy.
No studies were identified that addressed this question 
specifically as regards to the primary outcome of bile duct 
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injury or secondary outcomes of conversion, complications, 
or mortality, or proxy outcome of quality of the critical view 
of safety.
Question 8 Should immediate cholecystectomy defined as 
performed within 72 h of symptom onset be used in acute 
cholecystitis (AC) versus delayed cholecystectomy? Delayed 
cholecystectomy is defined either as: (a) between 72hrs and 
10 days after symptom onset; (b) 6–12 weeks after symptom 
onset; (c) greater than 12 weeks after symptom onset.
Recommendation In patients presenting with mild acute 
cholecystitis (according to Tokyo Guidelines), we suggest 
surgeons perform laparoscopic cholecystectomy within 72 h 
of symptom onset (conditional recommendation, very low 
certainty of evidence). For patients with moderate and severe 
cholecystitis there is insufficient evidence to make a recom-
mendation, particularly as it relates to the outcome of bile 
duct injury.
Summary of evidence Data were analyzed from a system-
atic review that consisted of 14 randomized trials [128] and 
one large population study [129]. The included randomized 
studies did not include AC severity grading raising the pos-
sibility that the subgroup of patients with moderate and 
severe cholecystitis were underrepresented. Another large 
population study showed that grading of severity was criti-
cally important in evaluating the rate of bile duct injury in 
cholecystectomy for acute cholecystitis [126]. In that study, 
patients with AC had a significantly higher BDI rate than 
patients without AC primarily due to a higher BDI risk in 
patients with moderate cholecystitis (TG Grade 2) RR 0.53 
(95% CI 0.31 to 0.90). Patients with mild AC (TG Grade 
1) did not have a higher incidence of BDI. In severe AC 
(TG Grade 3) there was a non-significant trend toward an 
increased rate of injury. In patients who had one or more 
prior attacks there was a significantly higher incidence of 
BDI. Also, there is concern that the existing evidence may 
be limited in its generalizability by the fact that there is vari-
ability in how the diagnosis of acute cholecystitis is made, 
and there is reason to be concerned that the administrative 
diagnostic codes may have included patients with acute bil-
iary pain but no acute inflammation.
Narrative synthesis The effect of the timing of cholecys-
tectomy in patients with AC on the occurrence of BDI and 
other outcomes has been the subject of multiple studies that 
consist of 18 randomized controlled trials, more than 70 
observational trials, 8 meta-analyses of randomized con-
trolled trials, and a systematic review of the meta-analyses. 
Of the 8 meta-analyses reviewed, the one by Cao et al. [128] 
(R-AMSTAR score 33/44) was selected for inclusion on 
the basis that it was recent, included almost all pertinent 
randomized controlled trials (14 in all), and the authors 
provided unpublished explanatory information. Of the mul-
tiple non-randomized studies evaluated, only the popula-
tion-based propensity score-matched study by de Mestral 
et al. [129] was included. Several other timing studies not 
included in the GRADE analysis are discussed in Online 
Appendix 7 (http://links .lww.com/SLA/B992) [130–134].
Serious methodological problems in regard to standardi-
zation and other issues resulted in a low level of certainty 
in regard to conclusions. Awareness of these methodologic 
pitfalls is essential to interpretation of results and conclu-
sions and to guide future studies. These include:
Underpowering due to very low incidence variables
A study adequately powered to detect a threefold drop in 
BDI from 0.3% to 0.1% at a 95% confidence limit would 
require 9000 patients, which is about 5 times more patients 
than are present in the largest available meta-analysis of 
RCTs. Mortality is a similarly affected variable. Only popu-
lation-based studies containing many thousands of patients 
are likely to have the number of events required to study a 
problem with such a low event rate.
Failure to demonstrate parity in pre‑existing health 
status between early and delayed groups
Age, weight, and comorbidities can influence outcomes 
in patients undergoing cholecystectomy. These and other 
potential confounders have a potential biasing effect and 
are in need of parity in comparative studies. For instance, 
in a recent large population-based study, patients undergo-
ing early cholecystectomy were younger, more frequently 
female, less likely to have biliary tract obstruction, and had 
a lower co-morbidity burden [129]. These biases may be 
correctable by propensity score matching as was done in 
this study.
Questionable diagnosis of acute cholecystitis 
by diagnostic coding
The Tokyo Guidelines (TG) established the first standard 
diagnostic criteria for AC consisting of one symptom, one 
sign, and a confirming radiologic finding—the TG Triad. 
The 2013 version (TG13) of these diagnostic criteria were 
validated by comparison to pathologic findings and found to 
have sensitivity and specificity of 91.2% and 96.9%, respec-
tively [135]. Many studies, especially observational stud-
ies use hospital discharge diagnosis of AC, which is based 
on admission diagnosis, operative report diagnosis, and 
pathologic report diagnosis. Coding may not be accurate 
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when the admission and operative diagnoses are AC and 
the pathologic diagnosis is not. The frequency of use of the 
standard diagnostic triad in studies of AC by our analysis 
was adequate in RCTs (18 studies, of which 13 were evalu-
able and 10 used the triad) [128] but inadequate in many 
observational studies [133] (of 45 evaluable studies, 22 used 
the triad).
Inappropriate inclusion of cases done 
during the period of maximal inflammation 
in the “delayed” group
The debate over early versus delayed cholecystectomy is 
a question of whether it is better to operate in an “early” 
acute inflammatory phase after onset of symptoms, or to 
operate in a “delayed” manner after the acute inflammation 
has lessened. Although there is not universal agreement on 
the time intervals covered by the two terms, there is agree-
ment that there is an unfavorable intermediate period during 
which cholecystectomy is more difficult due to the predict-
able severity of inflammation. The span of this unfavorable 
intermediate period is at a minimum between 10 days and 
4 weeks. Studies that refer to surgeries done during that unfa-
vorable time as “delayed” are not waiting for acute inflam-
mation to subside, i.e., they are not adequately “delayed” 
which biases the results in favor of early cholecystectomy.
Failure to consider the relationship 
between severity of acute cholecystitis and bile duct 
injury
Until recently, severity grade has not been considered in any 
timing studies [134]. Tornqvist et al. in 2016 [126] studied 
the relation between severity of AC and BDI at cholecystec-
tomy using the 2013 Tokyo Guidelines (TG13) for diagnosis 
and severity grade of AC. The adjusted risk of BDI was dou-
bled among patients with AC (OR 1.97, 95% CI 1.05–3.72) 
compared to controls without AC. Patients with mild AC 
(TG13 Grade 1) had no increased risk of BDI (OR 0.96, 95% 
CI 0.41–2.25), but patients with moderate AC (TG Grade 2) 
had more than twice the risk (OR 2.41, 95% CI 1.21–4.80). 
Patients with severe AC (TG13 Grade 3) had a trend toward 
an even higher risk of AC (OR 8.43, 95% CI 0.97–72.9), but 
the number of patients was small. Patients with a prior his-
tory of attack(s) of AC had a significantly higher incidence 
of BDI also. This finding is consistent with multiple reports 
that prior attacks of AC are a risk factor for difficult opera-
tive conditions [136, 137].
Failure to consider severity grade in timing studies may 
result in confounding by inclusion of a higher proportion of 
patients with moderate cholecystitis in the delayed group 
because of a tendency to avoid early cholecystectomy when 
it is perceived that there is marked local inflammation. Also, 
a tendency to select patients with mild cholecystitis may 
result in studies which do not reflect accurately the influence 
of moderate inflammation on BDI.
Comparison of outcomes between early and delayed 
cholecystectomy
Seven outcomes were selected for analysis with BDI as the 
major outcome of interest.
Bile duct injury
All meta-analyses of RCTs were underpowered. Therefore, 
the large, propensity score-matched population-based study 
of de Mestral et al. [129] from the Province of Ontario, Can-
ada was selected for analysis. It reported on 7110 propensity 
matched pairs of early and delayed cholecystectomy patients 
who were matched by patient and surgeon characteristics. 
Early was defined as within 7 days of hospital admission and 
delayed was defined as delayed beyond the early time frame 
(interquartile range 4–12 weeks). After matching, BDI was 
significantly less common in the early group [OR 0.53 (95% 
CI 0.31–0.90)]. The certainty of the evidence is very low as 
the diagnosis was made by diagnostic code and severity of 
inflammation was not considered. The lowest quartile of the 
delayed group was operated before 4 weeks in the intermedi-
ate period of least desirable inflammatory conditions.
Mortality
Mortality was evaluated in 8 RCTs in the meta-analysis of 
Cao et al. (total of 1293 patients) [128]. There were only 
two deaths, one in the early group and one in the late group. 
The relative risk was 1.03 (95% CI 0.05 to 20.50, p = NS). 
The certainty of the evidence was very low. Severity was 
not graded, there was a low number of events, and there was 
a moderate risk of bias because most of the larger studies 
included in the meta-analysis were given a low 3/5 score 
on the Jadad scale [128]. In one RCT by Gutt et al. [138] 
comprising 618 of 1608 patients in the meta-analysis, the 
delayed group was operated between 1 and 7 weeks after 
presentation. Consequently, there is the possibility that many 
patients in the delayed group of this large RCT were oper-
ated before 4 weeks, i.e., in the intermediate period of unfa-
vorable inflammatory conditions. In the population-based 
study by de Mestral et al., the mortality rate in the early 
group was 0.46% and in the late group 0.64% [129]. The 
relative risk was 0.73 (95% CI 0.47–1.15, p = 0.21 NS).
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Conversion to open cholecystectomy
This variable was evaluated in 12 RCTs in the meta-analysis 
of Cao et al. [128] (total of 1452 patients). The conversion 
rate was 13.4% in the early group and 15.4% in the delayed 
group. The relative risk was 0.86 (95% CI 0.65 to 1.13), 
p = NS. The certainty of the evidence was also very low for 
this variable for the same reasons as above for mortality.
Patients with complications
Nine RCTs in the meta-analysis of Cao with 1276 patients 
were available for study [128]. Complications occurred in 
15% of patients in the early group (92/625) and 30% in the 
delayed group (192/643). The relative risk of the number of 
patients with complications in the early compared with the 
delayed group was 0.66 (95% CI 0.42–1.03, p = 0.07). In 
the 10 RCTs that reported total complications, there were 
158 events in 630 patients in the early group and 273 events 
in 646 patients in the delayed group (p = 0.03). The cer-
tainty of the evidence was very low for this variable for the 
same reasons as above for mortality and conversion to open. 
There was also wide CI and suboptimal information size and 
results were inconsistent across trials included in the meta-
analysis [I2 = 50.82, p = 0.04].
Duration of surgery
Duration of surgery was reported for 1276 patients in 10 
RCTs in the Cao meta-analysis [128]. The mean duration of 
surgery was 99 min in the early group which was slightly but 
not significantly longer than in the delayed group (86 min, 
p = 0.23). The certainty of the evidence was very low.
Length of total hospitalization
In the meta-analysis, there were 11 RCTs with 1383 patients 
related to this variable [128]. Mean total length of hospi-
tal stay was 4.1 days in the early group vs 7.3 days in the 
delayed group (p < 0.001). The certainty of the evidence was 
low as severity was not graded and there was moderate risk 
of bias. The large treatment effect raised the certainty of 
evidence one level.
Wound infection
In the meta-analysis of Cao et al. [128] wound infections 
were reported in 8 RCTs containing 1145 patients. In the 
early group, the incidence of wound infection was 4.2%, and 
in the delayed group, it was 6.2%. The relative risk in early 
and delayed groups was 0.57 [95% CI 0.35–0.93, p = 0.02].
Re‑presentation before scheduled delayed 
cholecystectomy
In the meta-analysis, 4 RCTs reported on re-presentation 
in the delayed group after initial successful non-operative 
treatment [128]. Of patients treated non-operatively initially, 
18.5% re-presented prior to having delayed cholecystectomy. 
Eight studies reported the need for urgent surgery prior to 
the scheduled date in the delayed group. Emergency laparo-
scopic cholecystectomy was needed earlier than the planned 
date in 9.7% of patients initially treated non-operatively.
Justification The evidence indicates that patients with 
mild AC do not have an increased rate of BDI whereas 
patients with moderate AC have double the incidence of 
BDI. However, because studies have not matched patient 
groups appropriately for the presence of moderate chole-
cystitis, it cannot be determined whether early or delayed 
cholecystectomy is superior in terms of the risk of BDI in 
that group of patients. Since BDI is the main outcome meas-
ure examined in the consensus conference and is a highly 
morbid, costly complication which necessitates invasive 
procedures and has a long-term effect on the quality of 
life of patients, it supersedes all other outcome measures 
in importance. Therefore, despite the superiority of early 
cholecystectomy in terms of total patient hospitalization, 
wound infection, and the need for unexpected care while 
waiting for cholecystectomy, the recommendation for early 
cholecystectomy can only be made in patients who have 
mild cholecystitis. The recommendation does not imply that 
delayed cholecystectomy is superior in patients with moder-
ate severity AC. Further studies that incorporate the severity 
of the disease are needed to answer this question.
Recommendations for future studies
Regarding the need to grade severity of AC and history 
of prior attacks of AC
Studies that examine the relationship between BDI and AC 
should match patients at baseline both for severity grade of 
AC and history of prior attacks of AC.
Method of diagnosis of AC
The diagnosis of AC should be documented in future studies 
following well-accepted clinical criteria such as TG18 diag-
nostic criteria, histologic findings of acute inflammation, or 
both. If documentation of AC is based on diagnostic codes 
such as ICD codes, investigators should ensure that the diag-
nostic codes confirm with the preceding criteria.
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Regarding classification of timing of surgery in studies 
of acute cholecystitis
In AC, for the purposes of reporting standardization and 
ability to compare results among studies, we suggest that the 
interval between onset of symptoms and time of operation 
should be defined in 4 phases:
Phase 1  Onset of symptoms to 72  h. Inflammation 
expected to be favorable for cholecystectomy. 
Tissue swelling due to edema.
Phase 2  72 h to 10 days. Inflammation expected to be 
less favorable for cholecystectomy. Due to tissue 
swelling and increased vascularity.
Phase 3  10 days to 6 weeks. Inflammation expected to be 
much less favorable for cholecystectomy. Acute 
and chronic inflammation.
Phase 4  6 weeks or later. Inflammation expected to be 
more favorable again for cholecystectomy. Pre-
dominately chronic inflammation.
There is also some justification for a period greater than 
12 weeks but there is very little information in the literature 
that this time period had been the subject of study.
Question 9 Should subtotal cholecystectomy versus total 
laparoscopic or open cholecystectomy be used for mitigat-
ing the risk of BDI in marked acute inflammation or chronic 
biliary inflammatory fusion (BIF)?
Recommendation When marked acute local inflammation 
or chronic cholecystitis with biliary inflammatory fusion 
(BIF) of tissues/tissue contraction is encountered during 
laparoscopic cholecystectomy that prevent the safe identifi-
cation of the cystic duct and artery, we suggest that surgeons 
perform subtotal cholecystectomy either laparoscopically or 
open depending on their skill set and comfort with the pro-
cedure (expert opinion).
Summary of evidence No direct comparative evidence 
was found addressing this question. Indirect qualitative com-
parisons from case series of subtotal cholecystectomy ver-
sus total cholecystectomy was considered critically flawed 
because of non-exchangeability of surgical populations due 
to confounding by indication for subtotal versus total chol-
ecystectomy (see also discussion Question 2).
Narrative synthesis Only one article directly compared 
subtotal cholecystectomy (STC) to laparoscopic total chol-
ecystectomy (LC) with bile duct injury (BDI) as an outcome 
metric [86]. This retrospective study used administrative 
data from the University HealthSystem Consortium Data-
base to compare LC to STC. Patients who underwent laparo-
scopic subtotal cholecystectomy were older (56 vs 48 years), 
more likely male (54.2% vs 32.3%), and had higher severity 
of illness scores on admission (9.2% vs 3.5%) [p < 0.001] 
compared to standard LC. On univariate analysis, patients 
who underwent STC experienced longer lengths of stay 
(4 vs 3 days), higher readmission rates (11.9 vs 7.0%) and 
higher mortality (0.82 vs 0.28%) [p < 0.05]. Following a 1:1 
propensity score match, no differences in outcomes were 
demonstrated between patient groups. Thus, the authors 
concluded that STC is a safe and feasible alternative to LC 
in well-selected patients. The strength of this conclusion is 
dampened by the retrospective nature of the study and con-
founding variables such as intraoperative details, surgeon 
factors and patient factors which were not accounted for.
Of the remaining articles assessed, none directly com-
pared outcomes and focused on the safety and feasibility of 
each technique. A systematic review identified 30 studies 
of 1200 patients who underwent subtotal cholecystectomy 
[71]. BDI was the primary outcome measure with other 
complications as secondary outcomes. The approach was 
laparoscopic in 72.9%, open in 19.0%, and laparoscopic con-
verted to open in 8.0%. Reasons for cholecystectomy were 
AC in 72%, cirrhosis/portal hypertension in 18.2%, gangrene 
or perforation in 6.1%, and Mirizzi syndrome in 3%. BDI 
was reported in 0.08%, bile leak in 18.0%, sub-hepatic col-
lections in 2.9%, retained stones in 3.1% of patients, need 
for post-op ERCP in 4.1%, and reoperation in 1.8%. The 
mortality rate was 0.4%. When outcomes of laparoscopic vs 
open subtotal cholecystectomy were compared, the laparo-
scopic approach was associated with less risk of sub-hepatic 
collection (OR 0.4, 95% CI 0.2–0.9), retained stones (OR 
0.5, 95% CI 0.3–0.9), wound infection (OR 0.07, 95% CI 
0.04–0.2), reoperation (OR 0.5 95% CI 0.3–0.9), and mortal-
ity (OR 0.2, 95% CI 0.05–0.9), but had more bile leaks (OR 
5.3, 95% CI 3.9–7.2). Bile leaks resolved spontaneously in 
31.2%. Of note, there was no standardization of technique 
across the various studies for how subtotal cholecystectomy 
was performed and outcomes were not compared to total 
cholecystectomy.
Justification Because no admissible direct or indirect evi-
dence addressed this guideline question, the panel deemed 
that a subtotal cholecystectomy is likely to limit the risk 
of BDI when operative conditions prevent clear anatomic 
identification by avoiding dissection in the hepatocystic tri-
angle. Both open and laparoscopic approaches for subtotal 
cholecystectomy were considered relevant based on patient 
and surgeon factors.
Question 10 Should standard 4-port lap cholecystectomy 
versus reduced port laparoscopic cholecystectomy (single 
incision laparoscopic cholecystectomy, SILC) versus robotic 
cholecystectomy versus open cholecystectomy versus other 
techniques be used for limiting the risk or severity of bile 
duct injury in candidates for cholecystectomy?
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Recommendation For patients requiring cholecystectomy, 
we suggest using a multi-port laparoscopic technique instead 
of single port/single incision technique (conditional recom-
mendation, moderate certainty of evidence).
Summary of evidence No direct comparative evidence 
addressed this outcome. Indirect comparison was made 
from evidence from two systematic reviews (includ-
ing total > 507,918 patients) of single arm cohort studies 
of single port versus standard port approach. The pooled 
effect estimate for BDI was 0.72% (simple average of the 
data across studies) vs. 0.32 to 0.52% (pooled range). The 
outcomes on which results favored single port laparoscopic 
cholecystectomy were analgesic use, cosmesis, and qual-
ity of life. The magnitude of these effects was imprecise as 
well as clinically small to trivial. The undesirable effects 
for single port laparoscopic cholecystectomy include BDI, 
total severe complication, operative time, port site hernia, 
and conversion to open procedure. The magnitude of these 
effects was conservatively judged moderate by the panel.
Narrative synthesis In a 2012 systematic review of BDI 
in SILC [139] (45 cohort studies, n = 2626), a pooled rate of 
BDI with SILC of 0.72% was found, potentially representing 
a higher rate of BDI than reported in previously reported 
large-scale pooled data for 4-port LC (0.32–0.52%) [11]. A 
2018 meta-analysis of 24 randomized trials (n = 4518) com-
paring SILC to 4-port LC reported a significantly increased 
incidence of major complications (Clavien-Dindo grade 
III or greater) in SILC, 2.7% vs. 1.1%, RR 2.02 (95% CI 
1.29–3.15) [140]. The quality of evidence in this review was 
moderate with good consistency of results.
Other outcomes were assessed by three smaller reviews, 
which were deemed of low or very low quality with high 
bias risk. Postoperative analgesia use was compared for 
SILC and 4-port LC in a 2013 review (2 cohort studies, 1 
RCT, n = 361). No difference was reported in postoperative 
opioid use, weighted mean difference − 3.78 mg (− 13.78 to 
6.22 mg) [141]. Conversion rates were compared for SILC 
and 4-port LC in a 2014 review (27 RCTs, n = 2049), with 
no difference between groups (0.2% in both groups) [142]. 
A 2014 Cochrane review of 9 RCTs of 4-port vs. reduced 
port LC (7 trials assessed SILC; 2 trials 3-port LC) reported 
longer operative time for reduced port LC (mean differ-
ence + 14.4 95% CI 6.0–23.0 min) [143].
Justification Although for individual outcomes, the cer-
tainty ratings ranged from very low to moderate, the evi-
dence on critical outcomes (BDI, severe complication) con-
sistently favored standard port laparoscopic cholecystectomy 
with certainty rating for severe complications judged to be 
moderate. As such, the highest certainty evidence informed 
overall certainty. Although there may be variability in how 
much patients value cosmesis, the panel believes that almost 
all patients will value the remainder of outcomes greater 
than cosmesis alone. Although evidence favors standard 
port, the panel acknowledged that in highly experienced 
hands, single port may yield similar outcomes as standard 
port.
Question 11 Should interval laparoscopic cholecystectomy 
versus no additional treatment be used for patients previ-
ously treated by cholecystostomy drainage?
Recommendation In patients with acute calculous cholecys-
titis previously treated by cholecystostomy who are good 
surgical candidates, we suggest that interval cholecystec-
tomy is preferred after the inflammation has subsided. For 
poor or borderline operative candidates, we suggest a non-
surgical approach that may include percutaneous stone clear-
ance through the tube tract or tube removal and observation 
if the cystic duct is patent (expert opinion).
Summary of evidence No direct comparative evidence 
was found that addressed this question. Making indirect 
comparisons from case series of patients treated by chol-
ecystostomy who had no additional treatment versus patients 
who had interval cholecystectomy was considered flawed 
because of non-exchangeability of the populations due to 
confounding in the predicted operative risks of the patients. 
Stated otherwise, in studies of this type, the group of patients 
who do not undergo interval cholecystectomy will be com-
posed of patients who are candidates for surgery as well as 
patients who are not candidates for surgery in unknown pro-
portions. Because such a group contains patients who are not 
candidates for cholecystectomy, they cannot be directly com-
pared to a group of patients all of whom were considered to 
be candidates for surgery and underwent cholecystectomy. 
We found no studies in which this issue was addressed by 
propensity scoring or randomization of fit candidates for 
surgery to cholecystectomy or observation.
Narrative synthesis A systematic review on the use of 
cholecystostomy as a treatment for AC performed in 2007 
identified 53 studies that included 1918 patients [144]. The 
short-term mortality after cholecystostomy tube placement, 
30-day or in-hospital, depending on which was reported in 
the manuscripts, was 15.4%. Thirty-eight percent of patients 
had an interval elective cholecystectomy and 4.5% required 
an emergent cholecystectomy. The operative mortality of 
patients undergoing elective interval cholecystectomy was 
0.96% and mortality was 13% in patients undergoing emer-
gent cholecystectomy. Emergent cholecystectomy included 
cholecystectomy during the index admission due to thera-
peutic failure and procedural complications in addition to 
patients experiencing recurrent cholecystitis after removal 
of the cholecystostomy tube.
A retrospective cohort study published in 2013, using 
a population-based administrative database from Canada, 
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identified 890 patients who had a cholecystostomy tube 
placed for acute cholecystitis from 2004 to 2011 [145]. In-
hospital mortality was 5%. At 3 months, 25% of patients had 
a cholecystectomy and 10% had died without undergoing 
cholecystectomy. At 1 year, 40% had cholecystectomy and 
18% had died. Thirty-day and 1-year postoperative mortality 
in the cholecystectomy group was 2% and 6%, respectively. 
In the 866 cholecystostomy patients discharged without 
cholecystectomy, the risk of gallstone-related emergency 
department visit or hospitalization was 23% at 3 months 
and 49% at 1 year. In-hospital mortality of gallstone-related 
admissions was 1%.
A single-center retrospective review from the USA iden-
tified 288 patients who had a cholecystostomy tube placed 
for acute calculous cholecystitis from 1997 to 2015 [146]. 
In-hospital mortality was 9%. Tube dysfunction occurred in 
46% of patients with 28% requiring re-intervention. Thirty-
six percent of patients underwent subsequent elective chole-
cystectomy, and the rate of recurrent biliary events was 6.8% 
vs 21.1% in patients who did not have a cholecystectomy 
(5.8% vs 18.5% at 1 year). The risk of biliary-related deaths 
in the patients who did not have a cholecystectomy was 5%. 
A single-center retrospective review from Denmark identi-
fied 278 patients who had a cholecystostomy tube placed 
for acute calculous cholecystitis from 2002 to 2012 [147]. 
Thirty-day mortality was 4.7%. Of 234 patients discharged, 
23.5% were readmitted for recurrent cholecystitis, 54.7% 
were followed for a median of 5 years without recurrence, 
and 21.8% had an elective interval cholecystectomy. In 
another single-center retrospective review from the USA, 
245 patients between 2009 and 2012 had a cholecystostomy 
tube placed [148]. Of the 202 patients who survived to dis-
charge, 48% had calculous cholecystitis and 41% had acal-
culous cholecystitis. Seventy-one patients (35%) were deter-
mined to be operative candidates, the majority of whom had 
calculous cholecystitis and had a planned interval cholecys-
tectomy. Two smaller series of 93 and 68 patients reported 
recurrent gallbladder disease in 19% and 41%, respectively, 
of patients who did not undergo planned interval cholecys-
tectomy [149, 150].
In addition to a patient’s surgical risk, the subgroups of 
patients with calculous and acalculous cholecystitis need to 
be considered. Some data in the literature demonstrates a 
lower risk of recurrent biliary symptoms after cholecystos-
tomy tube removal in patients with acalculous cholecystitis. 
The largest study, with 88 patients, demonstrated a 2.7% risk 
of recurrence over an 8-year follow-up [151]. Smaller studies 
have demonstrated a 7–14% risk of recurrence [152–154].
It should be noted that an important issue related to 
management of patients with a cholecystostomy tube is 
the indications for placement of a cholecystostomy tube. 
CHOCOLATE, a Dutch randomized trial that compared lap-
aroscopic cholecystectomy to percutaneous cholecystostomy 
in high-risk patients with acute calculous cholecystitis 
was recently published [155]. The results from this study 
strongly favor laparoscopic cholecystectomy over cholecys-
tostomy tube placement.
Justification In the available case series, the desirable 
anticipated effect of interval cholecystectomy is avoidance 
of recurrent gallbladder-related symptoms which occurred 
in 20–50% of patients who did not undergo interval chol-
ecystectomy. There is also some evidence that in this group 
recurrent symptoms were associated with urgent cholecys-
tectomy, which has a higher rate of open cholecystectomy 
and postoperative complications, whereas patients who 
undergo elective interval cholecystectomy are more likely to 
have the cholecystectomy completed laparoscopically with 
its associated benefits. The undesirable anticipated effect 
of interval cholecystectomy is increased cholecystectomy-
related complications including mortality. In the largest case 
series, the 30-day mortality after interval cholecystectomy 
was 2%. However, this will vary significantly based on cri-
teria used to select patients for elective interval cholecystec-
tomy. The available data is retrospective and it is likely that 
the patients selected for elective interval cholecystectomy 
were chosen for their perceived ability to tolerate surgery. 
The guideline panel judged, therefore, that in the subgroup 
of patients determined to be fit for surgery, the balance of 
effects favors the intervention, and the anticipated desirable 
effects were determined to be moderately substantial. In the 
subgroup of patients determined to be unfit for surgery, the 
balance of effects probably favors the alternative manage-
ment option.
Question 12 Should conversion of laparoscopic cholecystec-
tomy to open cholecystectomy versus no conversion be used 
for limiting the risk or severity of bile duct injury during 
difficult laparoscopic cholecystectomy?
Recommendation No recommendation was made as the 
current evidence comparing conversion versus no conver-
sion to open cholecystectomy to limit/avoid bile duct injury 
in the difficult cholecystectomy is insufficient.
Thirteen studies were reviewed but none fit within the 
criteria for this analysis. No evidence was found for the out-
come BDI or any of its proxy outcomes.
Recommendations for future studies: (1) We suggest 
the conduct of prospective and retrospective comparisons 
of clinical outcomes of various ‘bail-out’ options for the 
difficult cholecystectomy that include conversion to open, 
subtotal cholecystectomy, and procedure abandonment. (2) 
We further suggest the development and establishment of 
valid evidence for a ‘procedure difficulty score’ for lapa-
roscopic cholecystectomy and study of its effectiveness in 
limiting BDI risk.
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Question 13 Should surgeons take a time out to verify the 
critical view of safety versus no time out be used for limiting 
the risk or severity of bile duct injury during laparoscopic 
cholecystectomy?
Recommendation Current evidence is insufficient to make 
a recommendation. However, as a best practice, we suggest 
that during laparoscopic cholecystectomy, surgeons conduct 
a momentary pause for the surgeon to confirm in his/her 
own mind that the criteria for the critical view of safety have 
been attained before clipping or transecting ductal or arterial 
structures (expert opinion).
Of two studies reviewed, no evidence was found for the 
outcome BDI or any of its potential proxy outcomes [156, 
157]. While no evidence exists to answer this question, the 
GDG panel felt based on experience that the incorporation 
of a momentary pause to verify the appropriateness of the 
CVS before any structures has the potential to decrease the 
risk of BDI. As the most common cause of BDI is a mis-
perception of anatomy, the momentary pause is an oppor-
tunity to verify that what one is seeing is likely the correct 
anatomy. This practice should be easily implementable and 
without significant effort or delay required.
Recommendation for future studies We suggest incorpora-
tion of a “critical view momentary pause” in all prospective 
studies of laparoscopic cholecystectomy.
Question 14 Should two surgeons versus one surgeon be 
used for limiting the risk or severity of bile duct injury dur-
ing laparoscopic cholecystectomy?
Recommendation No recommendation was made as the 
current evidence comparing two versus one surgeons for 
limiting/avoiding bile duct injury in cholecystectomy is 
insufficient.
A single study was identified from the literature search, 
but was excluded as it did not include evidence for the out-
come BDI or any of its proxy outcomes [158]. Performing 
cholecystectomy with two surgeons present is not feasible 
in most settings. Given the potential beneficial effects of 
the presence of a second surgeon and the added experience 
that becomes available, the advice of a second surgeon is 
often very helpful under conditions in which the dissection 
is stalled, the anatomy is unclear, or under other conditions 
deemed “difficult” by the surgeon.
Retrospective assessment of case notes where the involve-
ment of multiple surgeons was recorded should be possible 
from billing and electronic records, and linkage of these 
cases to outcomes could provide insight into the usefulness 
of two-surgeon cholecystectomy. The effect of access to and/
or involvement of subspecialist hepatobiliary surgeons and 
impact on outcomes should also be assessed. Prospective 
multi-center cohort studies are desirable to capture the effect 
of multiple surgeon involvement in clinical outcomes.
Question 15 Should critical view of safety coaching of sur-
geons versus no specific critical view of safety coaching be 
used for limiting the risk or severity of bile duct injury dur-
ing laparoscopic cholecystectomy?
Recommendation We suggest as a best practice continued 
education of surgeons regarding the critical view of safety 
during laparoscopic cholecystectomy that may include 
coaching (conditional recommendation, very low certainty 
of evidence).
Summary of evidence Five studies were identified 
from the literature search for review. One study directly 
addressed this question but was not considered appropri-
ate for inclusion due to numerous flaws (underpowered to 
detect BDIs, inclusion of bile leaks as BDIs, confounding by 
surgeon skill) [159]. Therefore, one before and after study 
which addressed the proxy outcome of quality of CVS was 
included. In a group of five practicing surgeons who received 
CVS coaching, their scores on the Strasberg scale improved 
significantly from 1.75 at baseline to 3.75 after training (very 
low certainty evidence because of study design and fragility 
of effect) [160].
The GDG agreed that there was evidence from other 
surgical domains in support of this judgment. A systematic 
review of quality of evidence for surgical coaching and its 
impact on outcomes reported a positive impact on surgi-
cal performance, with strong evidence particularly in the 
domain of technical skills [161]. A 2015 randomized trial 
reported significantly improved global and technical per-
formance in porcine LC when comparing coaching to no 
coaching [162].
Justification Obtaining a high-quality “critical view” was 
considered paramount by the GDG to avoid BDI during lap-
aroscopic cholecystectomy. Given that current evidence sug-
gests that the majority of surgeons do not routinely obtain 
the CVS [160], and the benefits of education and coaching 
in improving performance and changing behavior demon-
strated in several fields including surgery [161], the GDG 
felt that coaching should be employed to improve the qual-
ity of dissection and of the CVS and may lead to decreased 
risk of BDI.
Question 16 Should training of surgeons by simulation 
methods or video-based education versus alternative surgeon 
training be used for limiting the risk or severity of bile duct 
injury during laparoscopic cholecystectomy?
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Recommendation No recommendation was made as the 
current evidence comparing simulation or video-based 
training versus alternative surgeon training modalities on 
limiting/avoiding bile duct injury during laparoscopic chol-
ecystectomy is insufficient.
Five studies were identified from the initial literature 
search [163–167]. No evidence was found for the outcome 
BDI or any of its proxy outcomes.
Recommendation for future studies We suggest the con-
duct of prospective large-scale multi-center studies to deter-
mine the role of simulation vs video-based vs alternative 
surgeon training modalities on limiting/avoiding BDI. More 
realistic simulators incorporating immersive virtual technol-
ogy and advanced haptics should be considered for develop-
ment, and their effectiveness studied.
Question 17 Should more surgeon experience versus less 
surgeon experience be used for mitigating the risk bile duct 
injury associated with laparoscopic cholecystectomy?
Recommendation We suggest that surgeons have a low 
threshold for calling for help from another surgeon when 
practical in difficult cases or when there is uncertain of 
anatomy (conditional recommendation, very low certainty 
of evidence).
Summary of evidence From 23 studies identified from 
the initial literature search, a single 2014 observational 
study was included which examined 53,632 LC’s from a 
US billing database and linked surgeon codes to the Funda-
mentals of Laparoscopic Surgery (FLS) database [7]. The 
authors reported that more experienced surgeons (mean 20.7 
vs. 6.1 years in practice) experienced a lower rate of BDI 
(0.14% vs. 0.47%, p = 0.0013, RR 0.27[95% CI 0.13–0.57]) 
compared to less experienced surgeons.
Justification Despite the large effect size and effectively 
non-existent undesirable effects, a strong recommendation 
was not provided due to acceptability and feasibility con-
siderations, especially in smaller community hospitals or 
rural areas (where only one surgeon may be available). The 
GDG felt that senior support could be sought for difficult 
cases identified pre- or intraoperatively, or that referral to 
more experienced centers should be considered where such 
support is not available.
Recommendation for future studies We suggest the con-
duct of prospective research studies to develop evidence-
based guidelines and measure the impact of interventions 
(such as the SAGES Safe Cholecystectomy initiative) 
for physicians who are in transition in practice/from resi-
dency/fellowship to  independent practice, in order to 
mitigate the risk of BDI associated with laparoscopic 
cholecystectomy.
Additional studies to measure the impact of surgeon expe-
rience on outcomes in LC are needed. Prospective compari-
sons of the effectiveness of the various BDI mitigating train-
ing methods on the laparoscopic cholecystectomy outcomes 
of early career surgeons should be considered.
Question 18 For patients with bile duct injury during lapa-
roscopic cholecystectomy (in the OR or early postoperative 
period), should the patient be referred to a specialist with 
experience in biliary reconstruction or should the recon-
struction be performed by the operating surgeon?
Recommendation When a bile duct injury (BDI) has 
occurred or is highly suspected at the time of cholecystec-
tomy or in the postoperative period, we recommend that 
surgeons refer the patient promptly to a surgeon with expe-
rience in the management of BDI in an institution with a 
hepatobiliary disease multispecialty team. When not feasible 
to do so in a timely manner, prompt consultation with a sur-
geon experienced in the management of BDI should be con-
sidered (strong recommendation, low certainty of evidence).
Summary of evidence No randomized control trials or 
systematic reviews were found that addressed this question. 
There were three retrospective studies and 44 case series, the 
majority of which include only patients with BDI repaired 
at expert centers. Studies of BDI series that compared out-
comes of repair by the primary surgeon/institution vs HPB 
centers were considered flawed because they consisted 
mostly of failed primary repairs and lack a denominator of 
total repairs by the primary surgeon. Seven observational 
studies summarized below that included a total of 1392 
patients with BDI addressed this question and showed a 
large consistent effect across a number of outcomes (rates 
of cholangitis, bile leak, stricture, reoperation, other inter-
vention, and death) that favored specialist surgeons over 
primary surgeons. The studies were judged to be at high 
risk of bias due to unclear comparability and an unknown 
degree of missing data. An umbrella systematic review of 32 
systematic reviews covering 15 surgical procedures provided 
indirect evidence additionally favoring higher surgeon expe-
rience or volume (R-AMSTAR score 33/44) [168].
Narrative synthesis
1. Perera et al. [169] presented a series of 200 patients 
treated for major BDI with a median follow-up of 
60  months. In 52% of the cases the anatomy was 
described as “straightforward” during the LC; 72% 
of the injuries were a major type E injury and 13% a 
type D. Of 157 patients managed surgically, 112 (71%) 
underwent reconstruction by specialist HPB surgeons 
and 45 patients (29%) were operated by non-HPB sur-
geons prior to referral. Multivariate analysis showed that 
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on table repair done by non-specialist surgeons was an 
independent risk factors for recurrent cholangitis (33% 
vs 11%), biliary strictures (69% vs 17%), redo recon-
structions (53% vs 3%), and overall morbidity (82% vs 
25%), p < 0.001.
2. Stewart et al. [170] reported outcomes in 137 patients 
with BDI repaired by HPB surgeons after no prior 
attempt at repair compared to 163 patients referred 
after repairs by the primary surgeon. The success rate 
of repair by HPB surgeons was 90.5% vs. 20.9% with 
primary surgeon repair.
3. Xu et  al. [171] examined outcomes of repair of 77 
patients with BDI across 15 provinces in China. The 
success rate of repair by HPB specialists in 42 patients 
was 83.3% compared to a success rate of 31.4% in 35 
patients repaired by the primary surgeon.
4. DeReuver [172] in a study of 500 BDIs referred found 
on multivariate analysis that factors associated with 
failure included secondary referral after prior surgical, 
endoscopic, or radiologic interventions.
5. Sicklick et al. [173] reported a single institution retro-
spective analysis on 200 patients treated for major BDI. 
Eighty-one patients (44%) had attempted repairs at out-
side institutions prior to referral. Only 15 of 89 repairs 
(17%) required no further reoperation. In 31 patients 
(34.8%), the original laparoscopic surgeon performed 
an end-to-end ductal anastomosis and in 18 patients 
(22.5%) the surgeon was unable to repair the injury. 
Definitive repair at the specialty center with a Roux-
en-Y hepatico-jejunostomy was carried out in 98% of 
patients. Complications occurred in 42.9% of patients 
but no patient required reoperation.
6. Thomson et al. [174] reported on 123 BDI, 87 (70.7%) 
occurring during LC and 33 (26.8%) during open chol-
ecystectomy. Of 55 patients who had an attempted repair 
prior to referral, only 12 (22%) required no further sur-
gical intervention. Of the 42 patients who required fur-
ther surgery, 27 had a failed primary ductal repair at the 
outside institution. A successful outcome of repair was 
achieved by a team experienced in the management of 
BDI in 89% of cases.
7. Rystedt et al. [175] reported results of early repair in 140 
of 155 bile duct injuries detected during laparoscopic 
cholecystectomy, 90 of which were initially repaired by 
the index surgeon. The most common repair was suture 
over T-tube and only 17% of patients had a Roux-en-Y 
hepatico-jejunostomy. In this study, 59% of the injuries 
were Hannover Grade C1 (< 5 mm lesion). Strictures 
were reported at 6 months in 18% of patients.
Notably, two studies found that outreach programs in which 
an experienced HPB surgeon travels to the primary center 
can also achieve good outcomes [174, 176].
Together these studies suggest that early referral to a ter-
tiary center with experienced hepatobiliary surgeons and 
associated interventional radiologic and endoscopic ser-
vices appears necessary to ensure optimal results. In addi-
tion, abundant indirect evidence from other surgical domains 
has previously established a positive relationship between 
surgeon volume and surgical outcomes. Quantitative, pooled 
data from an umbrella systematic review covering 15 sur-
gical procedures that included abdominal aortic aneurysm, 
colorectal cancer, esophagectomy, pancreatic cancer resec-
tion, and other procedures favored higher surgeon experi-
ence or volume [168]. Non-pooled results from individual 
studies on the Norwood procedure, trauma, bariatric surgery, 
radical prostatectomy, total knee arthroplasty, and coronary 
artery bypass also supported the same relationship between 
improved outcomes and surgeon volume.
Justification In summary, there is a strong clinical ration-
ale and both direct and indirect evidence favoring specialty 
repair despite the very low certainty of direct evidence 
addressing this question. Consequently, the GDG invoked 
one of the 5 paradigmatic situations for a strong recommen-
dation originating in this setting (potential for catastrophic 
harm) [34]. The complexity in assessing the extent of BDI 
and potential associated vascular injury, as well as the type 
of surgery entailed in the repair, are significantly different 
than for laparoscopic cholecystectomy. Therefore, high-vol-
ume experience in LC cannot be generalized to outcomes of 
repairs of BDI. No concerns were noted by the panel regard-
ing the generalizability of the systematic review evidence. 
Further, the undesirable effects secondary to a potential 
delay related to a specialist referral were considered small 
or trivial, contingent to preparing the patient well for such 
a referral/transfer, i.e., placement of drains by primary sur-
geon. As such, the balance of benefit and harms were judged 
to strongly favor the intervention. Consequences of a poorly 
repaired or failed repair of BDI include catastrophic harms 
such as cholangitis, bile leak, biliary stricture, sepsis, need 
for reoperation or other interventions, and liver failure, all 
of which may potentially lead to death.
Recommendations for future studies Implementation 
pathways should be developed with creation of regional fast 
tract BDI referral pathways to offer advice and contribute 
to immediate treatment strategies when a BDI due to LC 
occurs.
Additional Panel Recommendation We suggest the devel-
opment of national quality improvement initiatives for the 
prevention of bile duct injuries following cholecystectomy. 
The initiative(s) should be capable of identifying and char-
acterizing bile duct injuries in the population under study.
One of the challenges of efforts to impact the rate of BDI 
is that it is extremely difficult to define the actual incidence 
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and whether it might change over time. In order to deter-
mine this, large numbers of cholecystectomies need to be 
evaluated, and the administrative data that is currently used 
for this purpose from payors or other groups has inherent 
limitations, inaccuracies, and significant risk of bias. BDI 
is not just a U.S.A. or North American phenomenon, it is a 
worldwide phenomenon, which is why quality improvement 
initiatives should be at the national level whether within a 
country, a region, or within a professional surgical organiza-
tion or society. The collective weight of the societies partici-
pating in this conference should work toward implementa-
tion strategies to move this recommendation forward.
Discussion
Bile duct injury is the most common severe complication 
of cholecystectomy. It is very morbid, greatly increases the 
cost of care, and often leads to litigation. For a procedure 
that is normally outpatient, with the expectation of an almost 
immediate return to normal activity, the consequences can 
be devastating. Since the 1992 NIH sponsored consensus 
conference on LC [177], there has been no consensus-type 
meeting focused on the safety of this operation despite sub-
stantial evolution of the field. This 2018 conference brought 
together experts from several surgical organizations with 
different principal areas of expertise to develop evidence-
based recommendations in collaboration with the SAGES 
Guidelines committee.
In the initial consensus voting process, only three rec-
ommendations did not meet the 80% threshold for approval 
by the 25 voting experts (Questions 3, 9, and 13). Ques-
tions 9 and 13 were revised based on the meeting discus-
sion and feedback and were re-voted on electronically by 
the expert panel and approved (96.2% and 88.5% agree-
ment, respectively). Audience voting participation at the 
meeting was concordant for approval with expert voting 
with discrepancies on Question 4 (88.5% expert panel vs 
77.3% audience) and Question 6 Recommendation A1 
(85% expert panel vs 77.3% audience).
Dissemination of BDI guidelines
The dissemination of these guidelines broadly throughout 
the surgical community will require engagement of diverse 
stakeholders. Guideline recommendations will be promoted 
on society websites (such as the sages.org/safe-cholecystec-
tomy-program) and through panel sessions at meetings of 
surgical societies. To reach an international audience, trans-
lation of the guideline document into other languages will be 
investigated. Engaging surgeons through social media such 
as specialty Facebook groups (e.g., SAGES Masters Biliary 
Facebook group) and networks of online communities which 
engage community surgeons are needed. The guidelines 
should also be distributed to hospitals, healthcare systems, 
healthcare plans, malpractice insurers, and patient safety 
organizations. Finally, dissemination into general surgery 
training programs in the US and worldwide will be critical 
to impacting the next generation of practicing surgeons.
Implementation of guidelines and adoption
Guideline implementation will be undertaken by an imple-
mentation team consisting of members of the GDG and 
stakeholder societies that will meet periodically until the 
next guideline update. The team will continually evaluate 
barriers and facilitators (e.g., through stakeholder surveys) 
of guideline adoption. The team will include members of 
the SAGES Safe Cholecystectomy Task Force and Guide-
lines Committee along with representatives from the other 
consensus conference society members. The team will also 
ensure professional development opportunities and coaching 
and monitor the effectiveness of guideline implementation 
using pre-specified outcome measures. This approach will 
help ensure that relevant changes are made to the existing 
implementation plan as needed.
Limitations
The quality of evidence of many studies was low with result-
ant moderate to high risk of bias for many key questions. 
This resulted in many conditional or expert opinion-based 
recommendations. For some questions, few relevant studies 
were available which precluded formulation of a recommen-
dation. Randomized trials in which BDI is an outcome are 
not feasible because of the low frequency of BDI that would 
necessitate enrollment of a very large number of patients 
(> 5000) per arm. Proxy outcomes for BDI may be used in 
some cases such as identification of anatomy, but the degree 
of correlation with the primary outcome of BDI is unknown. 
A final limitation is that direct involvement of patients with 
BDI and their families was not included in the consensus 
meeting, although every effort was made to consider that 
perspective in the GDG deliberation process.
Future research recommendations
An important aspect of these guidelines is the provision 
of recommendations for future research studies. Areas for 
future investigation include the role of new imaging modali-
ties in high-risk populations, risk stratification for surgery 
and timing of cholecystectomy, education and training strat-
egies to reduce biliary injury, and development of national 
or society related registries. The low incidence of BDI at 
any one institution and the absence of national registries for 
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tracking BDI makes the study of this problem and efforts 
to impact it challenging. Current observational studies are 
underpowered with limited generalizability, as most origi-
nate from single institutions and/or report sample sizes too 
small to adequately detect BDI. Studies with adequate sam-
ple size are often derived from claims or administrative data 
that are at high risk of bias and lack the clinical nuance nec-
essary to identify key patient and operative elements criti-
cal to the prevention of BDI. Therefore, the development of 
national quality improvement initiatives for the identification 
and tracking of BDIs following cholecystectomy should be 
one of the most important steps taken going forward.
Updating BDI guidelines
These guidelines will be reviewed and updated within five 
years of publication. In addition, the literature on BDI and 
cholecystectomy will be monitored annually for new pub-
lications that pertain to the key questions and recommen-
dations from this guideline. It is also anticipated that the 
recommendations for future research, based on evidence 
and knowledge gaps identified in this review, will lead to 
the formation of well-designed, prospective studies that will 
enhance understanding of areas of controversy in the field.
Summary
The persistence of BDI rates as the most serious complica-
tion of laparoscopic cholecystectomy despite technologi-
cal advances requires a concerted intervention to enhance 
the safety of this common operation. The evidence-based 
guideline recommendations from this consensus effort are an 
important step toward recognition of key strategies surgeons 
can employ going forward and have considerable potential 
to positively impact patient outcomes. The identification of 
future research studies should lead to the design of clini-
cal and educational research initiatives that can drive fur-
ther improvement in the quality of surgical care for patients 
undergoing cholecystectomy.
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